Back

A randomized controlled clinical trial evaluating the safety and efficacy of a radiofrequency ablation transseptal puncture system

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Heart failure ablation Catheter Ablation of Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Huimin Chu

Ningbo First Hospital, Ningbo (China)

6 More presentations in this session

Presentation thumbnail
Discussant - Heart failure ablation
Presentation thumbnail
Pulsed field ablation: a new standard for single-shot atrial fibrillation ablation
Doctor C. Gregorio (Lisbon, PT)
Abstract
Presentation thumbnail
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a monocentric retrospective cohort study
Doctor V. Buia (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
Differential effect of low-voltage area ablation on atrial tachycardia recurrence in diabetic versus non-diabetic patients with persistent atrial fibrillation: sub-analysis of the SUPPRESS-AF Trial
Doctor K. Inoue (Osaka, JP)
Abstract
Presentation thumbnail
Impact of adjunctive posterior wall isolation with pulsed field ablation on inducibility of atrial flutter following pulmonary vein isolation
Doctor S. Mccoy (New York, US)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Heart failure ablation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources